Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lurasidone 80 mg
DRUG
3 trials
Sponsors
Sumitomo Pharma America, Inc.
, University of California, Irvine
Conditions
Schizophrenia
Phase 2
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
Completed
NCT00044044
Sumitomo Pharma America, Inc.
Schizophrenia
Start: 2002-07-31
End: 2003-05-31
Updated: 2014-04-17
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study
Completed
NCT01911429
Sumitomo Pharma America, Inc.
Schizophrenia
Start: 2013-08-31
End: 2015-12-31
Updated: 2017-04-18
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
Completed
NCT01979679
University of California, Irvine
Schizophrenia
Start: 2008-12-31
Updated: 2013-11-08
Related Papers
Assessment of Negative Symptoms in Clinical Trials of Acute Schizophrenia: Test of a Novel Enrichment Strategy
Schizophrenia Bulletin Open
2022-01-01
8 citations
The Efficacy and Safety of Lurasidone in Adolescent Patients with Schizophrenia: Results of Functional and Quality of Life Measures from a 6-week, Double-blind, Placebo-controlled Study
European Psychiatry
2017-04-01
1 citations
The Efficacy of Lurasidone on PANSS Subscales in Adolescent Patients with Schizophrenia: Results from a 6-week, Double-blind, Placebo-controlled, Multicenter Study
European Psychiatry
2017-04-01
1 citations
149. Effect of Lurasidone on Quality of Life, Function, and Metabolic Parameters in Adolescent Patients With Schizophrenia: Results From a 6-Week, Double-Blind, Placebo-Controlled Study
Schizophrenia Bulletin
2017-03-01
1 citations
SA114. Lurasidone for the Treatment of Adolescent Patients With Schizophrenia: Effect on PANSS Subscales
Schizophrenia Bulletin
2017-03-01
1 citations